Key: ^ indicates (co-) first author; § indicates (co-)corresponding author

2024

Dong C^, Zhang F^, He E, ... & Chen S. (2024) Sensitive detection of synthetic response to cancer immunotherapy driven by gene paralog pairs. Patterns (revised)

Dong C, Zhang F, Verma N, ... & Chen S. (2024) TCPGdb: A comprehensive CRISPR screen database of T cell perturbation genomics for identification of critical T cell regulators. bioRxiv

Zhang F^, Chow RD^, He E, Dong C, ... Wang G & Chen S. (2024) Multiplexed inhibition of immunosuppressive genes with Cas13d for on-demand combinatorial cancer immunotherapy. Nature Biotechnology.

Zhang F^, Chow RD^, Dong C^, ... Chen S & Wang G. (2024) Rational design of immune gene therapy combinations via in vivo CRISPR activation screen of tumor microenvironment modulators. Cell (underreview)

Verma N, Renauer P, Dong C, ... & Chen S. (2024) Genome scale CRISPR screens identify actin capping proteins as key modulators of therapeutic responses to radiation and immunotherapy. Nature Communications (Revised)

Pereira M, Ribeiro DR, Berg M, Tsai AP, Dong C, et al. (2024) Amyloid pathology reduces ELP3 expression and tRNA modifications leading to impaired proteostasis. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease

2023

Liu E, Becker N, Sudha P, Dong C, ... & Walker BA. (2023) Alternative Splicing in Multiple Myeloma is Associated with the Non-Homologous End Joining Pathway. Blood Cancer J

Tsai AP, Dong C, Lin PB, ... & Landreth GE. (2023) Genetic variants of phospholipase C-γ2 alter the phenotype and function of microglia and confer differential risk for Alzheimer’s disease. Immunity

2022

Dong C, Reiter J, et al. (2022) Intron-Retention Neoantigen Load Predicts Favorable Prognosis in Pancreatic Cancer. JCO clinical cancer informatics

Tsai AP^, Dong C^, Lin PBC, et al. (2022) PLCG2 is Associated with the Inflammatory Response and is Induced by Amyloid Plaques in Alzheimer's Disease. Genome Medicine

Wu W, Syed F, Simpson E, Lee C, Garrick C, Dong C, et al. (2022) The Impact of Pro-Inflammatory Cytokines on Alternative Splicing Patterns in Human Islets. Diabetes

Johnson TS, Yu CY, Huang Z, Xu S, Wang T, Dong C, ... & Zhang J. (2022) Diagnostic Evidence GAuge of Single cells (DEGAS): a flexible deep transfer learning framework for prioritizing cells in relation to disease. Genome medicine

2021

Dong C, Cesarano A, et al. (2021) Intron retention-induced neoantigen load correlates with unfavorable prognosis in multiple myeloma. Oncogene

Tsai AP^, Lin PBC^, Dong C^, et al. (2021) INPP5D expression is associated with risk for Alzheimer's disease and induced by plaque-associated microglia. Neurobiology of disease

Liu S, Sun X, Li K, Zha R, Feng Y, Sano T, Dong C, et al. (2021) Generation of the tumor-suppressive secretome from tumor cells. Theranostics

Ma B, Jiang H, ... Dong C§ & Wang Y§. (2021) Tumor-Infiltrating Immune-Related Long Non-Coding RNAs Indicate Prognoses and Response to PD-1 Blockade in Head and Neck Squamous Cell Carcinoma. Frontiers in immunology

Liu J, Dong C, Liu Y and Wu H. (2021) CGPE: an integrated online server for Cancer Gene and Pathway Exploration. Bioinformatics

2020

Dong C, Liu J, et al. (2020) Highly robust model of transcription regulator activity predicts breast cancer overall survival. BMC medical genomics

Johnson TS, Christina Y, Dong C, et al. (2020) Development of a Novel Deep Transfer Learning Framework to Characterize Inter-and Intra-Tumor Heterogeneity in Myeloma Patients. Blood

2019

Liu, Y, Kim HG, Dong E, Dong C, Huang M, ... & Dong XC. (2019) Sesn3 deficiency promotes carcinogen-induced hepatocellular carcinoma via regulation of the hedgehog pathway. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease

Dong C, Christina Y, Johnson TS, , et al. (2019) A Highly Robust Model for Predicting Outcome of Multiple Myeloma Patients By Inferring Patient-Specific Transcription Factor Activity. Blood

Huang M, Kim HG, Zhong, X, Dong C, ... & Dong XC. (2019). Sesn3 protects against diet-induced nonalcoholic steatohepatitis in mice via suppression of the TGFβ signal transduction. Hepatology

Guo X, Wang Z, Zhang J, Xu Q, Hou G, Yang Y, Dong C, et al. (2019) Upregulated KPNA2 promotes hepatocellular carcinoma progression and indicates prognostic significance across human cancer types. Acta biochimica et biophysica Sinica

2018

Zheng S^, Luo X^, Dong C^, Zheng D, Xie J, Zhuge L, Sun Y, Chen H. (2018) A B7‐CD28 family based signature demonstrates significantly different prognoses and tumor immune landscapes in lung adenocarcinoma. International journal of cancer

2017 and before

Zheng S^, Zheng D^, Dong C^, et al. (2017) Development of a novel prognostic signature of long non-coding RNAs in lung adenocarcinoma. Journal of cancer research and clinical oncology

Liu G^, Zhan X^, Dong C^, et al. (2017) Genomics alterations of metastatic and primary tissues across 15 cancer types. Scientific reports

Hou G^, Dong C^, Dong Z, et al. (2017) Upregulate KIF4A enhances proliferation, invasion of hepatocellular carcinoma and indicates poor prognosis across human cancer types. Scientific reports

Liu, G, Dong C, and Liu L. (2016) Integrated multiple “-omics” data reveal subtypes of hepatocellular carcinoma. PloS one

Complete list of publications at Google Scholar https://scholar.google.com/citations?user=j89QLMoAAAAJ&hl=en&oi=ao.